Literature DB >> 3494813

Occurrence of multiple sclerosis in the north and south of New Zealand.

D C Skegg, P A Corwin, R S Craven, J A Malloch, M Pollock.   

Abstract

An impression that multiple sclerosis is commoner in southern parts of New Zealand than in the north has never been tested rigorously. Identical methods were used to determine the prevalence and incidence of multiple sclerosis in two regions: the Waikato (in the North Island) and Otago and Southland (in the South Island). No cases were found in Maoris, while the expected number was 11.7. The prevalence rate of multiple sclerosis (excluding possible cases) in non-Maoris was 24 per 100,000 in the northern region and 69 per 100,000 in the south. The incidence rate was also more than twice as high in the southern region. These findings are considered in relation to genetic and environmental hypotheses about the aetiology of multiple sclerosis.

Entities:  

Mesh:

Year:  1987        PMID: 3494813      PMCID: PMC1031483          DOI: 10.1136/jnnp.50.2.134

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  19 in total

1.  MULTIPLE SCLEROSIS AND POLIOMYELITIS.

Authors:  D C POSKANZER; K SCHAPIRA; H MILLER
Journal:  Lancet       Date:  1963-11-02       Impact factor: 79.321

2.  Multiple sclerosis. A note on social incidence.

Authors:  H MILLER; A RIDLEY; K SCHAPIRA
Journal:  Br Med J       Date:  1960-07-30

Review 3.  Epidemiology of multiple sclerosis.

Authors:  E D Acheson
Journal:  Br Med Bull       Date:  1977-01       Impact factor: 4.291

4.  Frequency of multiple sclerosis in three Australian cities--Perth, Newcastle, and Hobart.

Authors:  M G McCall; T L Brereton; A Dawson; K Millingen; J M Sutherland; E D Acheson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1968-02       Impact factor: 10.154

5.  Multiple sclerosis and HLA DQw1.

Authors:  D A Francis; J R Batchelor; W I McDonald; J E Hern; A W Downie
Journal:  Lancet       Date:  1986-01-25       Impact factor: 79.321

6.  President's address. The etiology of multiple sclerosis.

Authors:  G Dick
Journal:  Proc R Soc Med       Date:  1976-08

7.  Multiple sclerosis in New Orleans, Louisiana, and Winnipeg, Manitoba, Canada: follow-up of a previous survey in New Orleans, and comparison between the patient populations in the two communities.

Authors:  A Stazio; R M Paddison; L T Kurland
Journal:  J Chronic Dis       Date:  1967-05

8.  Annual incidence, prevalence, and mortality of multiple sclerosis in white South-African-born and in white immigrants to South Africa.

Authors:  G Dean
Journal:  Br Med J       Date:  1967-06-17

9.  Blood cells glutathione peroxidase activity and selenium in multiple sclerosis.

Authors:  G L Mazzella; E Sinforiani; F Savoldi; M Allegrini; E Lanzola; R Scelsi
Journal:  Eur Neurol       Date:  1983       Impact factor: 1.710

Review 10.  Selenium in human health and disease with emphasis on those aspects peculiar to New Zealand.

Authors:  C D Thomson; M F Robinson
Journal:  Am J Clin Nutr       Date:  1980-02       Impact factor: 7.045

View more
  14 in total

1.  Multiple sclerosis in Australia and New Zealand: are the determinants genetic or environmental?

Authors:  D H Miller; S R Hammond; J G McLeod; G Purdie; D C Skegg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-10       Impact factor: 10.154

2.  Risk factors for multiple sclerosis: race or place?

Authors:  A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-10       Impact factor: 10.154

3.  Multiple sclerosis in south Cambridgeshire: incidence and prevalence based on a district register.

Authors:  N Robertson; J Deans; M Fraser; D A Compston
Journal:  J Epidemiol Community Health       Date:  1996-06       Impact factor: 3.710

4.  Multiple sclerosis: nature or nurture?

Authors:  D C Skegg
Journal:  BMJ       Date:  1991-02-02

5.  Association of UV radiation with multiple sclerosis prevalence and sex ratio in France.

Authors:  S-M Orton; L Wald; C Confavreux; S Vukusic; J P Krohn; S V Ramagopalan; B M Herrera; A D Sadovnick; G C Ebers
Journal:  Neurology       Date:  2011-02-01       Impact factor: 9.910

6.  The contribution of mortality statistics to the study of multiple sclerosis in Australia.

Authors:  S R Hammond; D R English; C de Wytt; J F Hallpike; K S Millingen; E G Stewart-Wynne; J G McLeod; M G McCall
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-01       Impact factor: 10.154

7.  Class II HLA antigens in multiple sclerosis.

Authors:  D H Miller; R W Hornabrook; J Dagger; R Fong
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-05       Impact factor: 10.154

8.  Multiple sclerosis in the province of Ferrara : evidence for an increasing trend.

Authors:  E Granieri; N-T Economou; R De Gennaro; M R Tola; L Caniatti; V Govoni; E Fainardi; I Casetta
Journal:  J Neurol       Date:  2007-11-16       Impact factor: 4.849

Review 9.  Neuropsychological aspects of multiple sclerosis.

Authors:  J C Brassington; N V Marsh
Journal:  Neuropsychol Rev       Date:  1998-06       Impact factor: 7.444

Review 10.  Epidemiologic evidence for multiple sclerosis as an infection.

Authors:  J F Kurtzke
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.